• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床实践中的体外无泵介入式肺辅助:疗效的决定因素

Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy.

作者信息

Müller T, Lubnow M, Philipp A, Bein T, Jeron A, Luchner A, Rupprecht L, Reng M, Langgartner J, Wrede C E, Zimmermann M, Birnbaum D, Schmid C, Riegger G A J, Pfeifer M

机构信息

Department of Internal Medicine II, University Hospital of Regensburg, Franz-Josef-Strauss Allee 11, 93053 Regensburg, Germany.

出版信息

Eur Respir J. 2009 Mar;33(3):551-8. doi: 10.1183/09031936.00123608. Epub 2008 Nov 14.

DOI:10.1183/09031936.00123608
PMID:19010979
Abstract

Respiratory acidosis can become a serious problem during protective ventilation of severe lung failure. A pumpless arteriovenous interventional lung assist (iLA) for extracorporeal carbon dioxide removal has been used increasingly to control critical respiratory situations. The present study sought to evaluate the factors determining the efficacy of iLA and calculate its contribution to gas exchange. In a cohort of 96 patients with severe acute respiratory distress syndrome, haemodynamic parameters, oxygen consumption and carbon dioxide production as well as gas transfer through the iLA were analysed. The measurements demonstrated a significant dependency of blood flow via the iLA device on cannula size (mean+/-sd 1.59+/-0.52 L x min(-1) for 15 French (Fr), 1.94+/-0.35 L x min(-1) for 17 Fr, and 2.22 +/-0.45 L x min(-1) for 19 Fr) and on mean arterial pressure. Oxygen transfer capacity averaged 41.7+/-20.8 mL x min(-1), carbon dioxide removal was 148.0+/-63.4 mL x min(-1). Within two hours of iLA treatment, arterial oxygen partial pressure/inspired oxygen fraction ratio increased significantly and a fast improvement in arterial carbon dioxide partial pressure and pH was observed. Interventional lung assist eliminates approximately 50% of calculated total carbon dioxide production with rapid normalisation of respiratory acidosis. Despite limited contribution to oxygen transfer it may allow a more protective ventilation in severe respiratory failure.

摘要

在重症肺衰竭的保护性通气过程中,呼吸性酸中毒可能会成为一个严重问题。一种用于体外二氧化碳清除的无泵动静脉介入式肺辅助装置(iLA)越来越多地被用于控制危急的呼吸状况。本研究旨在评估决定iLA疗效的因素,并计算其对气体交换的贡献。在一组96例严重急性呼吸窘迫综合征患者中,分析了血流动力学参数、氧耗量和二氧化碳产生量以及通过iLA的气体交换情况。测量结果表明,通过iLA装置的血流量显著依赖于插管尺寸(15法氏(Fr)时平均±标准差为1.59±0.52 L·min⁻¹,17 Fr时为1.94±0.35 L·min⁻¹,19 Fr时为2.22±0.45 L·min⁻¹)以及平均动脉压。氧转运能力平均为41.7±20.8 mL·min⁻¹,二氧化碳清除量为148.0±63.4 mL·min⁻¹。在iLA治疗的两小时内,动脉血氧分压/吸入氧分数比值显著升高,同时观察到动脉二氧化碳分压和pH值迅速改善。介入式肺辅助可消除约50%计算得出的总二氧化碳产生量,使呼吸性酸中毒迅速恢复正常。尽管对氧转运的贡献有限,但它可能允许在严重呼吸衰竭时采用更具保护性的通气方式。

相似文献

1
Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy.临床实践中的体外无泵介入式肺辅助:疗效的决定因素
Eur Respir J. 2009 Mar;33(3):551-8. doi: 10.1183/09031936.00123608. Epub 2008 Nov 14.
2
Protective and ultra-protective ventilation: using pumpless interventional lung assist (iLA).保护性和超保护性通气:使用无泵介入性肺辅助(iLA)。
Minerva Anestesiol. 2011 May;77(5):537-44.
3
Switch from venoarterial extracorporeal membrane oxygenation to arteriovenous pumpless extracorporeal lung assist.从静脉动脉体外膜肺氧合转为动静外肺辅助无泵。
Ann Thorac Surg. 2010 Jan;89(1):125-31. doi: 10.1016/j.athoracsur.2009.09.007.
4
Extracorporeal lung membrane provides better lung protection than conventional treatment for severe postpneumonectomy noncardiogenic acute respiratory distress syndrome.对于严重的肺切除术后非心源性急性呼吸窘迫综合征,体外肺膜氧合比传统治疗提供更好的肺保护。
J Thorac Cardiovasc Surg. 2008 Jun;135(6):1362-71. doi: 10.1016/j.jtcvs.2007.08.074.
5
Extrapulmonary ventilation for unresponsive severe acute respiratory distress syndrome after pulmonary resection.肺切除术后无反应性重症急性呼吸窘迫综合征的肺外通气
Ann Thorac Surg. 2008 Jan;85(1):237-44; discussion 244. doi: 10.1016/j.athoracsur.2007.06.004.
6
Physiologic effect and safety of the pumpless extracorporeal interventional lung assist system in patients with acute respiratory failure--a pilot study.体外非泵式介入性肺辅助系统在急性呼吸衰竭患者中的生理效应和安全性:一项初步研究。
Artif Organs. 2012 Apr;36(4):434-8. doi: 10.1111/j.1525-1594.2011.01359.x. Epub 2011 Nov 1.
7
Pumpless extracorporeal removal of carbon dioxide combined with ventilation using low tidal volume and high positive end-expiratory pressure in a patient with severe acute respiratory distress syndrome.在一名严重急性呼吸窘迫综合征患者中,采用低潮气量和高呼气末正压通气联合无泵体外二氧化碳清除技术。
Anaesthesia. 2009 Feb;64(2):195-8. doi: 10.1111/j.1365-2044.2008.05735.x.
8
Bronchial fistulae in ARDS patients: management with an extracorporeal lung assist device.急性呼吸窘迫综合征患者的支气管瘘:应用体外肺辅助装置进行治疗
Eur Respir J. 2008 Dec;32(6):1652-5. doi: 10.1183/09031936.00021008.
9
[Techniques of extracorporeal lung support].[体外肺支持技术]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2008 Nov;43(11-12):786-91; quiz 793. doi: 10.1055/s-0028-1104619. Epub 2008 Nov 18.
10
Extracorporeal carbon dioxide removal using the Novalung in a patient with intracranial bleeding.在一名颅内出血患者中使用诺瓦肺进行体外二氧化碳清除。
Anaesthesia. 2007 Jan;62(1):72-4. doi: 10.1111/j.1365-2044.2006.04863.x.

引用本文的文献

1
Application of a novel extracorporeal membrane oxygenation system in awake Hu sheep under various durations.一种新型体外膜肺氧合系统在不同时长清醒湖羊中的应用
BMC Anesthesiol. 2025 Feb 6;25(1):59. doi: 10.1186/s12871-025-02930-5.
2
Advancing extracorporeal carbon dioxide removal technology: bridging basic science and clinical practice.推进体外二氧化碳清除技术:架起基础科学与临床实践的桥梁。
Med Gas Res. 2025 Jun 1;15(2):288-298. doi: 10.4103/mgr.MEDGASRES-D-24-00051. Epub 2024 Nov 8.
3
Effects of extracorporeal CO removal on gas exchange and ventilator settings: a systematic review and meta-analysis.
体外 CO 去除对气体交换和呼吸机设置的影响:系统评价和荟萃分析。
Crit Care. 2024 Apr 30;28(1):146. doi: 10.1186/s13054-024-04927-x.
4
Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.体外膜肺氧合期间发生肝素诱导的血小板减少症患者的患病率和结局。
PLoS One. 2022 Aug 8;17(8):e0272577. doi: 10.1371/journal.pone.0272577. eCollection 2022.
5
TPMS-based membrane lung with locally-modified permeabilities for optimal flow distribution.基于 TPMS 的局部渗透性改良膜肺,实现最佳血流分布。
Sci Rep. 2022 May 3;12(1):7160. doi: 10.1038/s41598-022-11175-y.
6
In Vitro and In Vivo Feasibility Study for a Portable VV-ECMO and ECCOR System.便携式静脉-静脉体外膜肺氧合(VV-ECMO)和体外心肺复苏(ECCOR)系统的体外和体内可行性研究
Membranes (Basel). 2022 Jan 22;12(2):133. doi: 10.3390/membranes12020133.
7
Life span of different extracorporeal membrane systems for severe respiratory failure in the clinical practice.不同体外膜肺系统在临床治疗严重呼吸衰竭中的寿命。
PLoS One. 2018 Jun 1;13(6):e0198392. doi: 10.1371/journal.pone.0198392. eCollection 2018.
8
Impact of membrane lung surface area and blood flow on extracorporeal CO removal during severe respiratory acidosis.严重呼吸性酸中毒期间膜肺表面积和血流量对体外二氧化碳清除的影响。
Intensive Care Med Exp. 2017 Dec;5(1):34. doi: 10.1186/s40635-017-0147-0. Epub 2017 Aug 1.
9
Fourteen Day In Vivo Testing of a Compliant Thoracic Artificial Lung.顺应性胸腔人工肺的十四天体内测试
ASAIO J. 2017 Sep/Oct;63(5):644-649. doi: 10.1097/MAT.0000000000000627.
10
Extracorporeal carbon dioxide removal (ECCOR) in respiratory deficiency and current investigations on its improvement: a review.呼吸功能不全时的体外二氧化碳清除(ECCOR)及其改善的当前研究:综述
J Artif Organs. 2017 Mar;20(1):8-17. doi: 10.1007/s10047-016-0905-x. Epub 2016 May 18.